Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Jan 2005
- 214-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't